Sanofi’s Oral TNF Experiment Runs Into Trouble in...
Category : Clinical Trial Update 26 May 2026Sanofi tested an oral small molecule drug called balinatunfib in a Phase 2 psoriasis trial. And i...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ascletis Tweaks Its Oral GLP-1 Strategy After Mixe...
Category : Clinical Trial Update 26 May 2026Ascletis Pharma Inc. has been testing an oral GLP-1 drug called ASC30 in early-stage clinical trials...
Infex Therapeutics announces positive phase IIa st...
Category : Clinical Trial Update 25 May 2026Infex Therapeutics, a leader in critical-priority infectious diseases, with a broad and diverse pipe...
Sobi announces positive topline results from pivot...
Category : Clinical Trial Update 25 May 2026Sobi, a global biopharma company unlocking the potential of breakthrough innovations, transforming e...
AbbVie Announces Positive CHMP Opinion for MAVIRET...
Category : Clinical Trial Update 25 May 2026The positive opinion is supported by data from the Phase 3 M20-350 study evaluating the safety and e...
Latest Newsletter Post
-
GSK and Ionis Report Positive Phase..
1 June 2026
-
Altimmune Reports Positive 48-Week..
1 June 2026
-
Jade Biosciences Doses First Patien..
27 May 2026
-
MediciNova Completes Phase 2 Trial..
27 May 2026
-
Ascletis Tweaks Its Oral GLP-1 Stra..
26 May 2026
